• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Corrigendum to “Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae” [Drug Resist. Updat. 66 (2023) 100891]
 
  • Details
  • Full
Options
July 2025
Erratum
Title

Corrigendum to “Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae” [Drug Resist. Updat. 66 (2023) 100891]

Author(s)
He, Jintao
Zhejiang University School of Medicine, Hangzhou, China
Shi, Qiucheng
Zhejiang University School of Medicine, Hangzhou, China
Chen, Zhifu
Third Military Medical University, Chongqing, China
Zhang, Wang
Zhejiang University School of Medicine, Hangzhou, China
Lan, Peng
Zhejiang University School of Medicine, Hangzhou, China
Xu, Qingye
Zhejiang University School of Medicine, Hangzhou, China
Hu, Huangdu
Zhejiang University School of Medicine, Hangzhou, China
Chen, Qiong
Zhejiang University School of Medicine, Hangzhou, China
Fan, Jiazhong
Zhejiang University School of Medicine, Hangzhou, China
Jiang, Yan
Zhejiang University School of Medicine, Hangzhou, China
Loh, Belinda Wei-Ching
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Leptihn, Sebastian
Zhejiang University School of Medicine, Hangzhou, China
Zou, Quanming
Third Military Medical University, Chongqing, China
Zhang, Jinyong
Third Military Medical University, Chongqing, China
Yu, Yunsong
Zhejiang University School of Medicine, Hangzhou, China
Hua, Xiaoting
Zhejiang University School of Medicine, Hangzhou, China
Journal
Drug resistance updates  
DOI
10.1016/j.drup.2025.101244
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024